ANXA7 and prostate carcinoma: To detect the possible mTOR involvement in the tumor suppressor effects of ANXA7 in prostate cancer cells, we juxtaposed the microarray-derived mTOR gene expression and apoptotic rates based on PS exposure and cell membrane permeabilization (ANXAV-PE, Figure 9B).